and facilitate targeted antibiotic therapy.” Mahmoud sees many advantages of adopting syndromic qPCR testing. “This technology promises quicker initiation of treatment, shorter hospital stays ...

we could solve the issues that are bothering our patient much faster and avoid unnecessary use of antifungals and antibiotics.” Vieira-Baptista sees a particular need for syndromic qPCR testing ...

Scientists have taken an important step toward the development of a potential new treatment for treating Shiga ...